Christopher B

US Head Of Oncology, Solid Tumors at Ipsen

Christopher B is a seasoned oncology professional with extensive experience in medical strategy and leadership roles. Currently serving as the US Head of Oncology for Solid Tumors at Ipsen, Christopher drives the medical strategy for solid tumor oncology, aligning with broader oncology goals. Previously held roles include US Head of Oncology at Pfizer, where Christopher led Medical Affairs for XTANDI in prostate cancer, and Senior Medical Director at GSK, overseeing global external medical engagement in oncology. Christopher also served as Principal Medical Science Liaison at The Janssen Pharmaceutical Companies, focusing on solid tumors and has a background in biomarker discovery at MolecularHealth. Christopher holds an MBA from Duke University and a Ph.D. in Cell and Molecular Biology from Baylor College of Medicine.

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices